Neogenomics Releases Investor Presentation

In a SEC filing dated 2018-02-21, Neogenomics Inc released their full Feburary 2019 Investor presentation. Investment Highlights  Leading publicly-traded, comprehensive, pure-play oncology testing company in the U.S.  Substantial Oncology/Genetics Market tailwinds  Significant near-term growth drivers  Market share gains driven by customer satisfaction  Rapidly growing Pharma Services business  Track record […]